1 |
Houkin K, Kamiyama H, Abe H, Takahashi A, Kuroda S : Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke 27 : 1342-1346, 1996
DOI
|
2 |
Im SH, Cho CB, Joo WI, Chough CK, Park HK, Lee KJ, et al. : Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg 14 : 75-78, 2012
DOI
|
3 |
Imai H, Miyawaki S, Ono H, Nakatomi H, Yoshimoto Y, Saito N : The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults. World Neurosurg 83 : 691-699, 2015
DOI
|
4 |
Jang DK, Lee KS, Rha HK, Huh PW, Yang JH, Park IS, et al. : Clinical and angiographic features and stroke types in adult moyamoya disease. AJNR Am J Neuroradiol 35 : 1124-1131, 2014
DOI
|
5 |
Jeon JP, Kim JE : NMR-based metabolomics analysis of leptomeningeal carcinomatosis. Neurosurgery 75 : N12-N13, 2014
|
6 |
Jeon JP, Yun T, Jin X, Cho WS, Son YJ, Bang JS, et al. : 1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease : comparison with unilateral moyamoya disease and atherosclerotic stenosis. Medicine (Baltimore) 94 : e629, 2015
DOI
|
7 |
Jeon JS, Ahn JH, Moon YJ, Cho WS, Son YJ, Kim SK, et al. : Expression of cellular retinoic acid-binding protein-I (CRABP-I) in the cerebrospinal fluid of adult onset moyamoya disease and its association with clinical presentation and postoperative haemodynamic change. J Neurol Neurosurg Psychiatry 85 : 726-731, 2014
DOI
|
8 |
Jeon JS, Sheen SH, Hwang GJ, Kim HC, Kwon BJ : Feasibility of intravenous flat panel detector CT angiography for intracranial arterial stenosis. AJNR Am J Neuroradiol 34 : 129-134, 2013
DOI
|
9 |
Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, Wang KC, et al. : Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery 58 : 1074-1080; discussion 1074-1080, 2006
DOI
|
10 |
Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, et al. : Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81 : 673-678, 2010
DOI
|
11 |
Kang HS, Wang KC, Kim SK : Circulating vascular progenitor cells in moyamoya disease. J Korean Neurosurg Soc 57 : 428-431, 2015
DOI
|
12 |
Kawaguchi S, Okuno S, Sakaki T : Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 93 : 397-401, 2000
DOI
|
13 |
Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK : Progression of unilateral moyamoya disease : a clinical series. Cerebrovasc Dis 22 : 109-115, 2006
DOI
|
14 |
Kim DS, Huh PW, Kim HS, Kim IS, Choi S, Mok JH, et al. : Surgical treatment of moyamoya disease in adults : combined direct and indirect vs. indirect bypass surgery. Neurol Med Chir (Tokyo) 52 : 333-338, 2012
DOI
|
15 |
Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, et al. : Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg 124 : 1221-1227, 2016
DOI
|
16 |
Kim T, Lee H, Bang JS, Kwon OK, Hwang G, Oh CW : Epidemiology of moyamoya disease in Korea : based on national health insurance service Data. J Korean Neurosurg Soc 57 : 390-395, 2015
DOI
|
17 |
Kim JE, Jeon JS : An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues. Neurol Res 36 : 407-416, 2014
DOI
|
18 |
Kim JE, Kim KM, Kim JG, Kang HS, Bang JS, Son YJ, et al. : Clinical features of adult moyamoya disease with special reference to the diagnosis. Neurol Med Chir (Tokyo) 52 : 311-317, 2012
DOI
|
19 |
Kim SJ, Heo KG, Shin HY, Bang OY, Kim GM, Chung CS, et al. : Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease : a prospective study. Stroke 41 : 173-176, 2010
DOI
|
20 |
Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, et al. : Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease. Stroke 34 : 2835-2841, 2003
DOI
|
21 |
Kim T, Oh CW, Kwon OK, Hwang G, Kim JE, Kang HS, et al. : Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J Neurosurg 124 : 1788-1793, 2016
DOI
|
22 |
Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. : Prevalence and clinicoepidemiological features of moyamoya disease in Japan : findings from a nationwide epidemiological survey. Stroke 39 : 42-47, 2008
DOI
|
23 |
Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y; Research Committee on Moyamoya Disease in Japan : Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease : results of multicenter survey in Japan. Stroke 38 : 1430-1435, 2007
DOI
|
24 |
Liu W, Zhu S, Wang X, Yue X, Zhou Z, Wang H, et al. : Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult moyamoya disease. J Clin Neurosci 18 : 374-378, 2011
DOI
|
25 |
Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y : Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36 : 2148-2153, 2005
DOI
|
26 |
Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, Cho KS : Long-term followup results in 142 adult patients with moyamoya disease according to management modality. Acta Neurochir (Wien) 154 : 1179-1187, 2012
DOI
|
27 |
Lee SC, Jeon JS, Kim JE, Chung YS, Ahn JH, Cho WS, et al. : Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature. Acta Neurochir (Wien) 156 : 103-111, 2014
DOI
|
28 |
Liu JS, Juo SH, Chen WH, Chang YY, Chen SS : A case of Graves' diseases associated with intracranial moyamoya vessels and tubular stenosis of extracranial internal carotid arteries. J Formos Med Assoc 93 : 806-809, 1994
|
29 |
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. : Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6 : e22542, 2011
DOI
|
30 |
Mesiwala AH, Sviri G, Fatemi N, Britz GW, Newell DW : Long-term outcome of superficial temporal artery-middle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus 24 : E15, 2008
|
31 |
Chen PC, Yang SH, Chien KL, Tsai IJ, Kuo MF : Epidemiology of moyamoya disease in Taiwan : a nationwide population-based study. Stroke 45 : 1258-1263, 2014
DOI
|
32 |
Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS : Incidence, prevalence, and survival of moyamoya disease in Korea : a nationwide, population-based study. Stroke 45 : 1090-1095, 2014
DOI
|
33 |
Bang OY, Ryoo S, Kim SJ, Yoon CH, Cha J, Yeon JY, et al. : Adult moyamoya disease : a burden of intracranial stenosis in east asians? PLoS One 10 : e0130663, 2015
DOI
|
34 |
Chen JB, Liu Y, Zhou LX, Sun H, He M, You C : Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease. J Neurosurg 124 : 1215-1220, 2016
DOI
|
35 |
Cho WS, Chung YS, Kim JE, Jeon JP, Son YJ, Bang JS, et al. : The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg 122 : 82-89, 2015
DOI
|
36 |
Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ, et al. : Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke 45 : 3025-3031, 2014
DOI
|
37 |
Choi IJ, Cho SJ, Chang JC, Park SQ, Park HK : Angiographic results of indirect and combined bypass surgery for adult moyamoya disease. J Cerebrovasc Endovasc Neurosurg 14 : 216-222, 2012
DOI
|
38 |
Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : results of the Japan Adult Moyamoya Trial. Stroke 45 : 1415-1421, 2014
DOI
|
39 |
Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. : Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78 : 803-810, 2012
DOI
|
40 |
Nicholson JK, Lindon JC : Systems biology : metabonomics. Nature 455 : 1054-1056, 2008
DOI
|
41 |
Choi WS, Lee SB, Kim DS, Huh PW, Yoo DS, Lee TG, et al. : Thirteenyear experience of 44 patients with adult hemorrhagic moyamoya disease from a single institution : clinical analysis by management modality. J Cerebrovasc Endovasc Neurosurg 15 : 191-199, 2013
DOI
|
42 |
Smith ER, Scott RM : Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 24 : E17, 2008
|
43 |
Park YS, Min KT, Kim TG, Lee YH, Cheong HJ, Yeom IS, et al. : Age-specific eNOS polymorphisms in moyamoya disease. Childs Nerv Syst 27 : 1919-1926, 2011
DOI
|
44 |
Qian C, Yu X, Li J, Chen J, Wang L, Chen G : The efficacy of surgical treatment for the secondary prevention of stroke in symptomatic moyamoya disease : a meta-analysis. Medicine (Baltimore) 94 : e2218, 2015
DOI
|
45 |
Smith ER : Moyamoya biomarkers. J Korean Neurosurg Soc 57 : 415-421, 2015
DOI
|
46 |
Sun H, Wilson C, Ozpinar A, Safavi-Abbasi S, Zhao Y, Nakaji P, et al. : Perioperative complications and long-term outcomes after bypasses in adults with moyamoya disease : a systematic review and meta-analysis. World Neurosurg 92 : 179-188, 2016
DOI
|
47 |
Suzuki J, Takaku A : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 : 288-299, 1969
DOI
|
48 |
Gross BA, Du R : The natural history of moyamoya in a North American adult cohort. J Clin Neurosci 20 : 44-48, 2013
DOI
|
49 |
Fujii K, Ikezaki K, Irikura K, Miyasaka Y, Fukui M : The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2 : S194-S195, 1997
|
50 |
Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. : Genetics and biomarkers of moyamoya disease : significance of RNF213 as a susceptibility gene. J Stroke 16 : 65-72, 2014
DOI
|
51 |
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, et al. : Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111 : 927-935, 2009
DOI
|
52 |
Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT 3rd, et al. : Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37 : 1490-1496, 2006
DOI
|
53 |
Han H, Pyo CW, Yoo DS, Huh PW, Cho KS, Kim DS : Associations of moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci 18 : 876-880, 2003
DOI
|
54 |
Hong SH, Wang KC, Kim SK, Cho BK, Park MH : Association of HLADR and -DQ genes with familial moyamoya disease in Koreans. J Korean Neurosurg Soc 46 : 558-563, 2009
DOI
|
55 |
Paez MT, Yamamoto T : Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery 60 : E582; author reply E582, 2007
DOI
|
56 |
Tendler BE, Shoukri K, Malchoff C, MacGillivray D, Duckrow R, Talmadge T, et al. : Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety. Thyroid 7 : 625-629, 1997
DOI
|
57 |
Wurtz P, Raiko JR, Magnussen CG, Soininen P, Kangas AJ, Tynkkynen T, et al. : High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. Eur Heart J 33 : 2307-2316, 2012
DOI
|